The Weaponisation of AI for Political Game and the Future of Media Consumption

The Algorithm as Propagandist

Propaganda once required armies of writers, editors, and broadcasters. Today, it requires a single model prompt.

Artificial intelligence has democratised manipulation. From deepfakes to micro-targeted persuasion, from synthetic news anchors to generative outrage, politics now operates inside algorithmic architectures optimised for attention — not truth.

The new weapon of war is narrative.

Elections no longer hinge on rallies or manifestos. They hinge on recommendation engines. Platforms like YouTube, TikTok, and X shape political sentiment more powerfully than any debate.

AI personalises persuasion — delivering emotional precision strikes based on behavioural data. It knows which fear to trigger, which anger to exploit, which illusion to sustain.

The battlefield is not the street. It is the feed.

The Collapse of Verification

Truth verification has collapsed under the velocity of synthetic media. Deepfake audio, AI-written articles, and fabricated images flood the digital commons. Audiences cannot distinguish authenticity from artifice.

This epistemic crisis is not side effect — it is strategy. When truth becomes uncertain, control shifts from the informed to the manipulative.

In the age of weaponised AI, disbelief becomes default.

The Political Economy of Outrage

Media ecosystems now monetise emotion. Algorithms reward engagement, and engagement thrives on anger. AI-driven platforms have turned politics into performance, outrage into currency.

This economic logic erodes deliberation. Voters become spectators. Public discourse becomes theatre of resentment.

Outrage is not by-product. It is business model.

Nations exploit AI to manipulate foreign electorates, flood information networks, and destabilise rivals. Disinformation becomes form of soft power — low-cost, high-yield warfare.

The old deterrence of nuclear weapons is replaced by narrative deterrence — states threatening reputational destruction through algorithmic influence.

Geopolitics is now psychological.

Drone testing by Military Personnel | Adobe

The Future of Media Consumption

The weaponisation of AI is not merely political. It reshapes how humans consume reality itself. Media no longer informs; it immerses. Reality becomes subscription service curated by unseen algorithms.

In this landscape, journalism must evolve from reporting events to verifying existence. Truth becomes active process, not passive assumption.

Societies must relearn how to see.

Survival demands literacy, transparency, and algorithmic accountability. Democracies must build epistemic resilience — public education in recognising manipulation, legislating transparency, and designing trustworthy media infrastructures.

AI cannot be unmade, but its use can be civilised. The antidote to weaponised intelligence is ethical intelligence — systems aligned with truth rather than virality.

The Cultural Reckoning

Ultimately, the future of media consumption depends on citizens’ appetite for authenticity. If societies continue to crave outrage more than understanding, the algorithm will oblige.

Freedom in the age of AI will not be measured by access to information, but by ability to discern it.

Why Politics in the Age of Algorithms Matter

Transformation: Politics becomes algorithmic warfare.
Risk: Collapse of shared reality.
Imperative: Build epistemic resilience through education and transparency.
Future: Media redefined as active verification, not passive consumption.

About the Author

Anonymous Contributor — Insider with a View. An industry insider whose position demands anonymity, yet whose knowledge demands to be shared. Reveals the forces shaping industries from within.

‍

The City Must Learn to Live With Water

The modern city has spent more than a century attempting to make water disappear. Rain falls onto roofs, roads and pavements. Gutters collect it. Drains capture it. Pipes bury it. Pumps move it. Rivers are channelled. Wetlands are filled. Coastlines are defended. The engineering objective has largely been straightforward: separate water from urban life as efficiently as possible. That model is reaching its limits. Around 600 million urban residents already live with significant annual flood hazard, according to the World Bank. Globally, 1.81 billion people live in flood-prone areas, while annual urban flood losses could approach $50 billion by 2050. Rapid urbanisation, ageing drainage infrastructure, land subsidence and changing rainfall patterns are interacting with the basic physical reality that cities have covered enormous portions of naturally absorbent ground with concrete and asphalt. Yet the consequential story is not simply that cities need bigger drains. A different philosophy of urban resilience is emerging: parks designed to flood temporarily; streets shaped to carry cloudbursts; wetlands restored as infrastructure; plazas capable of storing stormwater; permeable landscapes that absorb rainfall; buildings elevated or adapted to tolerate inundation; sensors that reveal water movement in real time; and neighbourhoods organised around the understanding that some water cannot — and perhaps should not — be engineered away. The World Bank increasingly describes effective urban flood management as an integration of grey infrastructure, green infrastructure, nature-based systems, planning, warning systems and institutional reform, rather than reliance on any single engineering intervention. The conceptual reversal is enormous. For generations, successful urbanisation meant controlling nature sufficiently to construct the city. The next generation of urbanism may require something more intelligent: designing the city so nature can still function inside it.

The Price of Money Is Becoming Political Again

For much of the post-financial-crisis era, wealthy economies became accustomed to an extraordinary condition: money was cheap. Governments could borrow heavily, companies could finance expansion at modest rates, asset prices could rise on abundant liquidity, and households learned to treat low-cost mortgages as something approaching economic normality. That world is disappearing fast. Across major economies, long-term government borrowing costs have climbed towards levels not seen for years or decades. On 17 August, the US 30-year Treasury yield reached roughly 5.31 per cent, its highest level since 2007. Japan’s 10-year government bond yield subsequently approached 2.95 per cent, a three-decade high, while German borrowing costs have risen to 15-year highs. The OECD describes the present combination of elevated financing requirements and elevated yields as exceptional compared with the previous two decades. Behind those numbers is a larger structural contest. Governments need capital for debt refinancing, defence, infrastructure, pensions, healthcare and climate resilience. Technology companies require extraordinary sums for artificial-intelligence infrastructure. Energy systems require grids, generation and storage. Businesses require investment. Families require mortgages and credit. These demands do not occupy separate universes. They ultimately encounter the same fundamental economic resource: capital. And when many powerful institutions want more of it simultaneously, the price of money stops being an obscure financial-market variable. It becomes a question of who gets financed, at what price, and at whose expense.

Cancer Vaccines Are Becoming Personal

For more than a century, the word vaccine has largely meant prevention: teach the immune system to recognise a threat before disease takes hold. Cancer is forcing medicine to reconsider that architecture. A new generation of experimental therapies is attempting something considerably more individual: sequence a patient’s tumour, identify mutations particular to that cancer, manufacture instructions corresponding to selected tumour-specific targets, and teach the patient’s immune system to recognise what belongs to the cancer growing inside that particular body. On 19 August, Moderna and Merck announced that their Phase III trial of the investigational personalised mRNA therapy intismeran autogene, used with Merck’s checkpoint inhibitor Keytruda after surgery for high-risk melanoma, achieved statistically significant and clinically meaningful improvements in recurrence-free survival and distant-metastasis-free survival compared with Keytruda alone. The global trial enrolled 1,137 patients with resected stage IIB–IV melanoma. No new safety concerns were identified in the announcement. Full detailed Phase III results remain pending. The result matters because this is not simply another medicine administered to everyone carrying the same diagnosis. Intismeran is designed individually. Tumour and normal tissue are sequenced; mutations are analysed computationally; selected neoantigens — abnormal molecular features produced by the tumour — become the targets encoded into an mRNA therapy manufactured for that patient. Earlier Phase IIb evidence provides important context rather than a substitute for the unreleased Phase III detail. At five-year median follow-up, Moderna and Merck reported that intismeran plus Keytruda reduced the risk of recurrence or death by 49 per cent and distant metastasis or death by 59 per cent compared with Keytruda alone in that smaller study. The larger significance therefore extends beyond melanoma. Medicine has spent generations classifying disease so that patients with sufficiently similar conditions can receive sufficiently similar treatments. Personalised cancer vaccines suggest a different possibility: the diagnosis may identify the disease, while the tumour itself helps design the medicine. If that model succeeds across cancers, one of medicine’s great industrial achievements — standardisation — will begin coexisting with its apparent opposite: manufacturing treatment for one.